Who is sponsoring NCT03917602?

NCT03917602 is sponsored by University of Alexandria.

What drugs are being tested in NCT03917602?

Interventions in NCT03917602: human amniotic membrane plug with vitrectomy.

What condition does NCT03917602 study?

NCT03917602 studies Macular Holes.

Is NCT03917602 still recruiting?

NCT03917602 is currently completed. Last updated 24 March 2020.

Last reviewed 2020-03-24 · How we verify

NCT03917602

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Human Amniotic Membrane Plug for Large Macular Holes

Completed NA Last updated 24 March 2020

What this trial tests

NA trial testing human amniotic membrane plug with vitrectomy in Macular Holes in 15 participants. Completed in 31 January 2020.

Timeline

11 May 2019

Primary endpoint
31 December 2019

31 January 2020

Quick facts

Lead sponsor	University of Alexandria
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	15
Start date	11 May 2019
Primary completion	31 December 2019
Estimated completion	31 January 2020
Sites	1 location across Egypt

Drugs / interventions tested

human amniotic membrane plug with vitrectomy

Conditions studied

Macular Holes — all drugs for Macular Holes →

Sponsor

University of Alexandria

Who can join

5 and older, any sex, with Macular Holes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective, interventional, consecutive case series conducted in Alexandria university. The aim of the study is to evaluate the therapeutic efficacy of human amniotic membrane in promoting closure of large macular holes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Macular Holes

Currently open trials in the same condition.

NCT06211907 — Small Macular Holes Treated With Air · NA · recruiting
NCT06000111 — Duration of Face Down Positioning for Full-Thickness Macular Hole Repair · NA · recruiting
NCT04904679 — The Use of Amniotic Membrane or Internal Limiting Membrane for Large or Refractory Macular Holes: A Prospective Study · NA · active not recruiting
NCT03713268 — Intraoperative OCT Guidance of Intraocular Surgery II · recruiting

Other University of Alexandria trials

Trials by the same sponsor.

NCT03806439 — Post-surgical Delirium in Patients Undergoing Radical Cystectomy. · not yet recruiting
NCT03806413 — Post-surgical Delirium in Patients Undergoing Open Heart Surgery. · not yet recruiting
NCT04110132 — Postoperative Analgesia Using Ganglion Impar Block After Anal Surgery · NA · not yet recruiting
NCT06529627 — GDF-8 Levels in ICSI Cycles · NA · completed
NCT05306639 — Treatment of Monosymptomatic Nocturnal Enuresis · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03917602 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Alexandria
Last refreshed: 24 March 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03917602.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing